CAUSEWAY CAPITAL MANAGEMENT LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAUSEWAY CAPITAL MANAGEMENT LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$19,249,467
+9.3%
1,244,309
+11.0%
0.51%
+9.7%
Q2 2023$17,604,370
-5.4%
1,120,584
-0.8%
0.46%
+3.8%
Q1 2023$18,611,952
-10.3%
1,129,366
-15.1%
0.45%
-25.9%
Q4 2022$20,748,648
+11.8%
1,330,042
-7.0%
0.60%
+15.8%
Q3 2022$18,556,000
-12.3%
1,430,705
-5.1%
0.52%
-1.5%
Q2 2022$21,156,000
-7.7%
1,506,823
-5.9%
0.53%
-3.6%
Q1 2022$22,927,000
+11.5%
1,601,046
+6.1%
0.55%
+21.2%
Q4 2021$20,570,000
-34.1%
1,509,149
-20.9%
0.45%
-35.7%
Q3 2021$31,237,000
-8.6%
1,906,998
-6.1%
0.70%
+0.7%
Q2 2021$34,186,000
+11.9%
2,031,264
+21.4%
0.70%
+16.1%
Q1 2021$30,557,000
+8.7%
1,673,455
+8.4%
0.60%
+13.8%
Q4 2020$28,104,000
+6.5%
1,544,171
+4.4%
0.53%
+7.5%
Q3 2020$26,377,000
-4.5%
1,478,524
-4.0%
0.49%
-1.2%
Q2 2020$27,619,000
-16.3%
1,540,379
-29.1%
0.50%
-5.7%
Q1 2020$32,992,000
-33.2%
2,173,365
-13.1%
0.53%
-0.6%
Q4 2019$49,370,000
+13.5%
2,502,296
-1.0%
0.53%
+2.1%
Q3 2019$43,490,000
-3.6%
2,528,500
-0.8%
0.52%
+5.1%
Q2 2019$45,095,000
-7.3%
2,547,740
+6.7%
0.49%
+0.6%
Q1 2019$48,651,000
+31.2%
2,388,353
+8.3%
0.49%
+11.1%
Q4 2018$37,078,0002,204,3840.44%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
Adelphi Capital LLP 8,958,784$176,757,00033.75%
Ovata Capital Management Ltd 879,800$17,557,092,00013.04%
Paulson & Co. 13,244,711$261,318,0005.64%
Glenview Capital Management 30,582,721$603,397,0005.28%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 718,028$14,167,0004.85%
Velanne Asset Management Ltd 302,694$5,972,0003.52%
Blackcrane Capital, LLC 172,708$3,408,0002.72%
Melqart Asset Management (UK) Ltd 1,557,000$30,720,0002.57%
GMT CAPITAL CORP 3,345,976$66,016,0002.55%
REDWOOD CAPITAL MANAGEMENT, LLC 827,955$16,336,0002.24%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders